Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Macrogenics (MGNX) Return on Sales (2016 - 2025)

Historic Return on Sales for Macrogenics (MGNX) over the last 14 years, with Q3 2025 value amounting to 0.23%.

  • Macrogenics' Return on Sales fell 2800.0% to 0.23% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.52%, marking a year-over-year increase of 2500.0%. This contributed to the annual value of 0.45% for FY2024, which is 2900.0% down from last year.
  • Macrogenics' Return on Sales amounted to 0.23% in Q3 2025, which was down 2800.0% from 1.63% recorded in Q2 2025.
  • Over the past 5 years, Macrogenics' Return on Sales peaked at 0.51% during Q3 2024, and registered a low of 16.87% during Q2 2024.
  • Its 5-year average for Return on Sales is 3.18%, with a median of 3.04% in 2021.
  • Its Return on Sales has fluctuated over the past 5 years, first crashed by -133900bps in 2024, then soared by 152400bps in 2025.
  • Quarter analysis of 5 years shows Macrogenics' Return on Sales stood at 4.12% in 2021, then skyrocketed by 104bps to 0.16% in 2022, then tumbled by -2908bps to 4.6% in 2023, then surged by 92bps to 0.39% in 2024, then surged by 160bps to 0.23% in 2025.
  • Its Return on Sales was 0.23% in Q3 2025, compared to 1.63% in Q2 2025 and 3.24% in Q1 2025.